Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
9
LGVN Quote, Financials, Valuation and Earnings
Last price:
$0.53
Seasonality move
:
-25.8%
Day range:
$0.53 - $0.57
52-week range:
$0.53 - $2.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.95x
P/B ratio:
1.16x
Volume:
224K
Avg. volume:
475.3K
1-year change:
-67.25%
Market cap:
$11.5M
Revenue:
$2.4M
EPS (TTM):
-$1.34
Analysts' Opinion
-
Consensus RatingLongeveron, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.86, Longeveron, Inc. has an estimated upside of 1168.48% from its current price of $0.54.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.00 representing 100% downside risk from its current price of $0.54.
Fair Value
-
According to the consensus of 1 analyst, Longeveron, Inc. has 1168.48% upside to fair value with a price target of $6.86 per share.
LGVN vs. S&P 500
-
Over the past 5 trading days, Longeveron, Inc. has underperformed the S&P 500 by -4.05% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Longeveron, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Longeveron, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Longeveron, Inc. reported revenues of $137K.
Earnings Growth
-
Longeveron, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Longeveron, Inc. reported earnings per share of -$0.39.
Enterprise value:
3.3M
EV / Invested capital:
0.30x
Price / LTM sales:
5.95x
EV / EBIT:
--
EV / Revenue:
2.28x
PEG ratio (5yr expected):
-0.04x
EV / Free cash flow:
-0.19x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$115K
Return On Assets:
-98.24%
Net Income Margin (TTM):
-1485.11%
Return On Equity:
-122.24%
Return On Invested Capital:
-113.81%
Operating Margin:
-5335.77%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $767K | $1.9M | $1.4M | $773K | $137K | |
| Gross Profit | -$776K | $401K | -$115K | $448K | -$140K | |
| Operating Income | -$20.8M | -$17.7M | -$22.2M | -$4.6M | -$7.3M | |
| EBITDA | -$19.9M | -$16.7M | -$21M | -$4.4M | -$7M | |
| Diluted EPS | -$9.79 | -$6.33 | -$1.34 | -$0.34 | -$0.39 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $19.7M | $23.2M | $5M | $23.8M | $10.3M | |
| Total Assets | $27.3M | $30.6M | $11.7M | $29.9M | $15.6M | |
| Current Liabilities | $1.9M | $3.7M | $3.4M | $3.1M | $4.9M | |
| Total Liabilities | $4.8M | $5.9M | $5M | $4.3M | $5.6M | |
| Total Equity | $22.4M | $24.7M | $6.7M | $25.6M | $10M | |
| Total Debt | $3.4M | $2.2M | $1.6M | $983K | $336K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$17.3M | -$14.5M | -$16.7M | -$2.8M | -$5.1M | |
| Cash From Investing | $6.1M | $1M | -$654K | -$478K | -$118K | |
| Cash From Financing | -$346K | $34.3M | $3.8M | $13.7M | $4.1M | |
| Free Cash Flow | -$17.9M | -$15.6M | -$17.4M | -$3.3M | -$5.2M | |
LGVN
Sector
Market Cap
$11.5M
$28.1M
Price % of 52-Week High
24.15%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
-25.28%
-1.49%
1-Year Price Total Return
-69.44%
-17.13%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.57
200-day SMA
Sell
Level
$1.13
Bollinger Bands (100)
Sell
Level
0.59 - 0.99
Chaikin Money Flow
Sell
Level
-3M
20-day SMA
Sell
Level
$0.61
Relative Strength Index (RSI14)
Sell
Level
35.66
ADX Line
Sell
Level
38.38
Williams %R
Buy
Level
-89.0523
50-day SMA
Sell
Level
$0.71
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Sell
Level
-5.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.0329)
Sell
CA Score
(Annual)
Level (-3.1639)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (8.7314)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Stock Forecast FAQ
In the current month, LGVN has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LGVN average analyst price target in the past 3 months is $6.86.
-
Where Will Longeveron, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Longeveron, Inc. share price will rise to $6.86 per share over the next 12 months.
-
What Do Analysts Say About Longeveron, Inc.?
Analysts are divided on their view about Longeveron, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Longeveron, Inc. is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is Longeveron, Inc.'s Price Target?
The price target for Longeveron, Inc. over the next 1-year time period is forecast to be $6.86 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LGVN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Longeveron, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of LGVN?
You can purchase shares of Longeveron, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Longeveron, Inc. shares.
-
What Is The Longeveron, Inc. Share Price Today?
Longeveron, Inc. was last trading at $0.53 per share. This represents the most recent stock quote for Longeveron, Inc.. Yesterday, Longeveron, Inc. closed at $0.54 per share.
-
How To Buy Longeveron, Inc. Stock Online?
In order to purchase Longeveron, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get LGVN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LGVN
Sector
P/E ratio
--
23.89x
PEG ratio
-0.04x
-0.01x
P/B ratio
1.16x
1.81x
Price / LTM sales
5.95x
1.59x
Growth Metrics
LGVN
Sector
Revenue growth
-82.28%
4.62%
Earnings growth
-17.24%
11.06%
Revenue (5-year growth)
-15.76%
6.5%
Earnings forecast
--
-$0.21
Profitability
LGVN
Sector
Profitability FY 2024
$925K
$3.6M
Return on invested capital
-113.81%
-31.84%
Return on assets
-98.24%
-27.96%
Return on equity
-122.24%
-37.63%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
3
Balance Sheet
LGVN
Sector
Total cash
$9.2M
$26.4M
Short term investments
--
$25.7M
Total assets
$25.6M
$76.9M
Long term debt
$336K
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
Sell
32
SMX alert for Dec 24
SMX (Security Matters) Plc [SMX] is down 8.94% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
